Read more about the article Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands
Translumina & Everstone’s Senior management team with Shareholders of Blue Medical Devices - Wellinq Group Company

Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands

The acquisition gives access to a patented, innovative, and proven next-generation Drug Coated Balloon (DCB) technology that may revolutionize the scope of complex coronary interventions

Continue ReadingTranslumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands